SCIEX推出3200MD欧盟认可的体外诊断质谱系列用于欧洲的体外诊断
AB SCIEX launches 3200MD CE-IVDD series in Europe for in vitro diagnostic use
AB SCIEX, a global leader in analytical technologies, today announced the launch of the 3200MD CE-IVDD series for general in vitro diagnostic use in Europe.
“The use of LC/MS/MS technology for clinical diagnostics has already been proven to deliver faster, more accurate results at lower cost compared to existing technologies. Now, we are bringing these benefits to Europe in a way that will simplify and accelerate adoption of this powerful technology.”
Meeting regulatory requirements to obtain the CE-IVDD mark for the new AB SCIEX API 3200MD™ and 3200MD QTRAP® LC/MS/MS systems will provide European hospitals and clinical diagnostic laboratories the confidence to use these mass spectrometry-based systems to improve the quality of results in clinical analysis while reducing costs.
"We are focused on meeting the medical, technological and compliance needs of clinical diagnostic laboratories and hospitals," said Rainer Blair, President of AB SCIEX. "The use of LC/MS/MS technology for clinical diagnostics has already been proven to deliver faster, more accurate results at lower cost compared to existing technologies. Now, we are bringing these benefits to Europe in a way that will simplify and accelerate adoption of this powerful technology."
Today"s news announcement at the EuroMedLab conference in Milan, Italy follows on the heels of the company"s announcement of the family of 3200MD systems earlier this year. The 3200MD series is the company"s first of a family of in vitro diagnostic devices. The intended use of these devices is to identify inorganic or organic compounds in human specimens for clinical use.
AB SCIEX plans to continue to roll out regulatory-compliant systems around the world in the future. With these IVD devices, the company is delivering on its strategy to expand the use of its technology in clinical diagnostics, which is widely deemed a new frontier for mass spectrometry.
AB SCIEX has a two-decade track record of success in the clinical research (RUO) market. The company has excelled at advancing and simplifying LC/MS/MS technology, so it is easier for laboratories to adopt and utilize for routine analysis. The robustness and ease of use of the 3200 product line makes it a preferred instrument for research laboratories of all sizes. Now applying its expertise and experience to the IVD market, AB SCIEX is also expanding its service offerings to provide enhanced service and support specifically for clinical diagnostics.
The AB SCIEX API 3200MD™ and 3200MD QTRAP® LC/MS/MS systems are expected to ship in Europe by mid-June.
厂家名称
TripleTOF™ 5600 :具备三重四极杆性能的高分辨质谱 QTRAP™质谱:定性定量,完美结合 SCIEX是生命科学分析技术研发的全球领先者,帮助科学家们应对复杂的科学挑战。公司研发科学仪器、软件和服务,...
相关产品
最新新闻
- AB SCIEX Triple Quad? 4500MD 330万中标高效液相色谱仪三重四极杆质谱联用系统采购项目
- AB SCIEX QTRAP 6500+ 中标上海交通大学超高液相色谱—串联三重四极杆离子阱质谱分析系统项目
- SCIEX的何塞·卡斯特罗-佩雷斯(Jose Castro-Perez)揭示了他们如何为质谱法设定新标准
- SCIEX QTRAP 6500+三重四极杆液质联用仪380.5万中标:武汉大学高分辨离子淌度质谱仪、冷冻光电联用系统、晶格层光显微成像系统、三重四级杆液质联用仪采购项目
- SCIEX ZenoTOF 7600质量质谱仪 852.1万中标:复旦大学复杂生物基质中目标代谢组的精准定性定量分析系统采购项目